Identification of oxidized plasma proteins in Alzheimer's disease.
about
T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-AntitrypsinThe role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesiumThe roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic reviewBlood markers of oxidative stress in Alzheimer's diseaseInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingMass spectrometry-based methods for identifying oxidized proteins in disease: advances and challengesFunctional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.Diabetes and Cognitive Impairment.PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy.Hypochlorite-induced structural modifications enhance the chaperone activity of human α2-macroglobulin.Blood-based biomarkers of Alzheimer's disease: challenging but feasiblePrediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysisOxidative stress induced carbonylation in human plasmaMitochondrial transcription factor A regulation of mitochondrial degeneration in experimental diabetic neuropathy.Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.How proteomics reveals potential biomarkers in brain diseases.Improving image analysis in 2DGE-based redox proteomics by labeling protein carbonyl with fluorescent hydroxylamineTwo-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.Age-related oxidative modifications of transthyretin modulate its amyloidogenicityRedox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.Alzheimer's disease: are blood and brain markers related? A systematic review.Multiplex biomarkers in blood.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis.Clinical proteomics in neurodegenerative disorders.Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community.High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.Clinical diagnosis for discogenic low back pain.Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease.Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence.Proteomic research in psychiatry.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.Mass spectrometry and redox proteomics: applications in disease.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Analysis of protein carbonylation--pitfalls and promise in commonly used methods.Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study.
P2860
Q26829272-D717A422-9AA7-4AC5-AFDB-A86B22EF7701Q26859190-70B40A47-370F-40F1-A56E-188875E8C7A1Q27008396-933E882C-9A66-4202-B7CC-8A9003C65277Q27021625-C8568702-9FB0-4A34-B5C9-0C94B995F1DBQ28076999-174B75F9-313A-440E-A3A8-083263B1495DQ28382957-B866475D-BA97-4F41-A5E6-5AC1E6D78E2AQ30352067-96602A40-F9EB-41C3-837D-9EB6041D25E8Q31119662-0AF8BDC0-71DF-4C66-A8BA-4B6CBA6774B9Q33623182-2B1856C2-AEE4-44DF-8642-387F5E8B7A68Q33665370-1E6D34DA-F788-49C4-AACE-15C6637D1E14Q33824444-416A1691-0616-41B5-BC36-0427422FE325Q34466540-A4297962-4A7A-4D4F-9C64-5A8B42F5B595Q35422035-4939DB08-ABAA-459A-8402-EEF4C93CE327Q35859167-DC2147B8-79D3-49AB-9711-54190EDCD19BQ36203126-4F1D8774-701E-4210-8FF5-278C3CC538B0Q36322155-25A6CFD8-DE96-4BEF-9DEE-FCF48EA993EBQ36508745-ED1DFDD1-3DB7-4404-BA6D-EB8A20DD4FFBQ36525162-BEC8061D-D517-4F17-80BC-C42CFFD6D4B0Q36704037-0EE4EB92-F8A0-4D3C-86A0-5BAA85284A30Q36846943-D07D80B3-C535-4FBB-BD62-B1168D8F81CEQ36966044-F5B59B45-B263-4768-A122-06BD00840864Q36998638-F0F4853C-6509-4B22-946E-85F5C9A917E2Q37068847-8C9D6660-0C81-4657-A493-BB9B48373EBEQ37083385-D39BF678-4B57-4FBB-89AC-D4F06AB52C64Q37086170-39227C4F-4002-4A2F-B080-04C0170FA2E8Q37104395-A66E68C7-C73F-4179-8620-71ADC63FF48FQ37369954-CB57865A-FF2D-4D98-9E72-34D4DB7456B1Q37393285-CA5C7A47-2CE6-4821-B553-9907C1A57D37Q37433250-1052026E-B009-4831-AB60-20F19C48144AQ37581663-52142DDF-31B4-48A4-8ADF-DA555CD65F6EQ37689362-897EBCB8-6186-4953-A770-3AC19325374AQ38027217-60AC6D82-3E17-41E5-82A3-A2BC04202EC1Q38037157-B831CB2C-774F-4EC5-ADFE-5DA6FAAFED94Q38060574-9AC9E82A-F1F8-4F1D-9F59-C40E95178576Q38125769-DEAAAACD-0A7E-4E27-97B9-A0A278D82A79Q38203153-630C890B-0B9A-4DCA-A303-37AB7413CD9DQ38220377-9AA906BE-4A42-4FE0-9422-CACD5F426865Q38222874-C942D605-DF97-4F6F-A3B3-76E76B89B7CEQ38235078-58636D4D-D4A3-462C-89C2-DDF99413EC3BQ42784787-10611E32-A836-4527-B953-566B949D16A1
P2860
Identification of oxidized plasma proteins in Alzheimer's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of oxidized plasma proteins in Alzheimer's disease.
@ast
Identification of oxidized plasma proteins in Alzheimer's disease.
@en
type
label
Identification of oxidized plasma proteins in Alzheimer's disease.
@ast
Identification of oxidized plasma proteins in Alzheimer's disease.
@en
prefLabel
Identification of oxidized plasma proteins in Alzheimer's disease.
@ast
Identification of oxidized plasma proteins in Alzheimer's disease.
@en
P2093
P1476
Identification of oxidized plasma proteins in Alzheimer's disease.
@en
P2093
Christina A Malakowsky
Craig C Conrad
John M Talent
Joungil Choi
Robert W Gracy
P304
P356
10.1016/S0006-291X(02)00420-5
P407
P577
2002-05-01T00:00:00Z